ALEXANDRIA VIERLING: Open Payments
NPI 1982485249 · MONTGOMERY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$837 in 36 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $563 · 2025 $837
Food & beverage: $837
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $221 |
| Regeneron Healthcare Solutions, Inc. | 3 | $144 |
| QOL Medical, LLC | 6 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $51 |
| TerSera Therapeutics LLC | 1 | $20 |
| GENZYME CORPORATION | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 4 | $14 |
Products named: RINVOQ, ENTYVIO, Sucraid, XIFAXAN, DUPIXENT, SKYRIZI, EOHILIA, Xermelo.
Industry payments across OH — which companies pay providers there.
